Repository logo
 

Histone Acetyltransferase KAT2A Stabilizes Pluripotency with Control of Transcriptional Heterogeneity.

Published version
Peer-reviewed

Type

Article

Change log

Authors

Moris, Naomi 
Edri, Shlomit 
Seyres, Denis 
Kulkarni, Rashmi 
Domingues, Ana Filipa 

Abstract

Cell fate transitions in mammalian stem cell systems have often been associated with transcriptional heterogeneity; however, existing data have failed to establish a functional or mechanistic link between the two phenomena. Experiments in unicellular organisms support the notion that transcriptional heterogeneity can be used to facilitate adaptability to environmental changes and have identified conserved chromatin-associated factors that modulate levels of transcriptional noise. Herein, we show destabilization of pluripotency-associated gene regulatory networks through increased transcriptional heterogeneity of mouse embryonic stem cells in which paradigmatic histone acetyl-transferase, and candidate noise modulator, Kat2a (yeast orthologue Gcn5), have been inhibited. Functionally, network destabilization associates with reduced pluripotency and accelerated mesendodermal differentiation, with increased probability of transitions into lineage commitment. Thus, we show evidence of a relationship between transcriptional heterogeneity and cell fate transitions through manipulation of the histone acetylation landscape of mouse embryonic stem cells, suggesting a general principle that could be exploited in other normal and malignant stem cell fate transitions. Stem Cells 2018;36:1828-11.

Description

Keywords

Embryonic stem cells, Epigenetics, Gene expression pluripotency, Animals, Cell Differentiation, Genetic Heterogeneity, Histone Acetyltransferases, Humans, Mice, Pluripotent Stem Cells

Journal Title

Stem Cells

Conference Name

Journal ISSN

1066-5099
1549-4918

Volume Title

36

Publisher

Oxford University Press (OUP)
Sponsorship
Biotechnology and Biological Sciences Research Council (BB/J014540/1)
British Heart Foundation (None)
Kay Kendall Leukaemia Fund (KKL888)
Isaac Newton Trust (17.07(f))
Leuka (unknown)
BBSRC (1221216)
European Commission FP7 Network of Excellence (NoE) (282510)
Wellcome Trust, BBSRC, Isaac Newton Trust, Kay Kendall Leukaemia Fund, Leuka, British Heart Foundation
Relationships
Is derived from: